Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. März 2018 07:50 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Acquires Bottle It Inc., State-of-the-Art 27,000 Sq. Ft., Bottling Manufacturing Facility for Various Bottled Waters, Energy Drinks, Vitamin Shots, Tincture Bottles, Sprays, and Various Sized Food Containers

IRVINE, CA, March 19, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that Cannabis...
14. März 2018 14:00 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Enters Multi-Billion USD Beverage Industry as it Partners with Crown Baus to Distribute Non-Alcohol Versions of Crown Baus’ Newly Acquired Cannabia, The World’s First Cannabis Beer

IRVINE, CA, March 14, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that Cannabis...
05. März 2018 09:23 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing, Packaging & Cultivation Procedures are Pending CBIS and City Approvals

Grand Opening of First CBIS Pharmacies Expected Soon IRVINE, CA, March 05, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of...
27. Februar 2018 07:42 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Announces Beta Launch of iCannabinoid, a High-Tech, State-of-the-Art, Medical Marijuana Social Media Educational Website

IRVINE, CA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc., (OTC: CBIS) a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the beta...
22. Februar 2018 07:39 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles; Research Team Begins Evaluating Commercialization Options

IRVINE, CA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is very pleased to report the...
02. Februar 2018 15:07 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Expands 5-Year Agreement With Dana-Farber Cancer Institute to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of Cancers

IRVINE, CA , Feb. 02, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc., (OTC: CBIS) a U.S. company specializing in the development of cannabinoid-based medicines, has entered into an expanded...
31. Januar 2018 14:28 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Expands Cancer Portfolio to Include Leukemia Treatment Research Utilizing Cannabinoid-Based Medicines

IRVINE, CA , Jan. 31, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that the Company’s...
29. Januar 2018 13:37 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Prepares the Grand Openings for Its First Two Pharmacies in California and the Cannabis Science 2018 Black-Tie Gala Event Date to be Announced Right After the Grand Openings

IRVINE, CA, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that...
18. Januar 2018 08:23 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Announces an Overwhelming Response to its Groundbreaking Research on the Use of Cannabinoids in the Treatment of Cancers, Already Has More Views Than 91% of the Papers Published in all Frontiers Journals

IRVINE, CA, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to report very strong...
10. Januar 2018 13:08 ET | Quelle: Cannabis Science, Inc.

Cannabis Science Announces its Construction Project Management (CPMT) Teams in Support of the Company’s Initiative to Establish Pharmacies and Medical Centers in California and Throughout the U.S.

IRVINE, CA, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that it has...

Vorherige Seite

Nächste Seite